Interpretation of Microcytic Hypochromic Anemia on CBC
This CBC shows microcytic hypochromic anemia, which most commonly indicates iron deficiency anemia (approximately 80% of cases), though other conditions like thalassemia, anemia of chronic disease, and sideroblastic anemia should be considered in the differential diagnosis. 1
Laboratory Values Analysis
- MCV: 77 fL (low; normal range 79-97 fL)
- MCH: 23.7 pg (low; normal range 26.6-33.0 pg)
- MCHC: 30.6 g/dL (low; normal range 31.5-35.7 g/dL)
These values collectively indicate:
- Microcytosis (small red blood cells)
- Hypochromia (decreased hemoglobin content per cell)
Differential Diagnosis
1. Iron Deficiency Anemia (Most Likely)
- Most common cause of microcytic hypochromic anemia worldwide (~80% of cases) 1
- High-risk groups include infants, toddlers, premenopausal women, pregnant women, and elderly people 1
- Characterized by:
2. Anemia of Chronic Disease
- Second most common cause of microcytic anemia
- Caused by functional iron deficiency (disturbed iron utilization)
- Characterized by:
3. Thalassemia
- Genetic disorder of hemoglobin synthesis
- Characterized by:
- Very low MCV (often <70 fL)
- Normal serum ferritin
- Normal transferrin saturation
- Normal RDW 2
4. Sideroblastic Anemia
- Rare genetic disorders affecting heme synthesis
- Can present with microcytic hypochromic anemia
- May be responsive to vitamin B6 (pyridoxine) in some cases 4, 5
Recommended Diagnostic Approach
First-line testing:
Additional testing based on initial results:
Common Pitfalls to Avoid
- Relying solely on MCV or MCH without confirming iron status 2
- Misinterpreting ferritin levels in inflammatory states (ferritin is an acute phase reactant) 2
- Failing to investigate underlying causes of iron deficiency (e.g., GI bleeding, malabsorption) 2
- Overlooking rare causes like vitamin B6 deficiency in therapy-resistant cases 5
- Not considering concurrent deficiencies that may limit response to therapy 2
Treatment Considerations
Treatment depends on the underlying cause:
- Iron deficiency anemia: Oral iron supplementation (ferrous sulfate 200 mg twice daily) for 3 months after hemoglobin normalizes 2
- Anemia of chronic disease: Treatment of underlying condition 1
- Sideroblastic anemia: Some forms may respond to vitamin B6 (pyridoxine) 50-200 mg daily 4, 5
Monitor response with repeat CBC in 2-4 weeks, with target hemoglobin rise of ≥10 g/L within 2 weeks indicating good response to therapy 2.